Barriers to Coronavirus Disease 19 vaccination in patients with obesity
- PMID: 36075763
- PMCID: PMC9434950
- DOI: 10.1016/j.amjsurg.2022.08.021
Barriers to Coronavirus Disease 19 vaccination in patients with obesity
Abstract
Background: Patients with obesity are at a high risk of severe disease and death from Coronavirus Disease 2019 (COVID-19). Vaccination offers a safe and effective means of reducing this risk. The rate of COVID-19 vaccine refusal in patients with obesity is unknown.
Methods: Patients with obesity were administered validated questionnaires assessing COVID-19 fear, general vaccine hesitancy, and COVID-19-specific vaccine hesitancy.
Results: 507 participants completed the study. COVID-19 vaccine hesitancy was high: Fifteen percent of patients refused COVID-19 vaccine. Hesitancy related to other vaccines was also high: Eight percent of patients refused a vaccine in the past, and 15% delayed a vaccine. Fear of side effects and doubts regarding effectiveness were the most common reasons for vaccine refusal.
Conclusions: Despite high risk for complications, vaccine hesitancy is high among patients with obesity. Targeted public health interventions are critical to reduce vaccine hesitancy and improve vaccination rates.
Keywords: COVID-19; Obesity; Vaccination; Vaccine hesitancy.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
References
-
- Reuters COVID-19 Tracker. Reuters; 2021. https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countrie...
-
- Aschwanden C. Five reasons why COVID herd immunity is probably impossible. Nature. 2021;591(7851):520–522. - PubMed
-
- MacDonald N.E., Hesitancy SWGoV. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous